Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-27 Sale |
2024-02-27 7:54 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
3,405 | $0.7322 | $2,493 | 136,750 (Direct) |
View |
| 2023-11-30 Purchase |
2023-12-04 4:54 pm |
Viracta Therapeutics Inc. | VIRX | Rothera Mark President and CEO |
100,000 | $0.49362 | $49,362 | 100,000 (Direct) |
View |
| 2023-11-28 Sale |
2023-11-28 7:06 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
3,720 | $0.5 | $1,860 | 140,155 (Direct) |
View |
| 2023-08-28 Sale |
2023-08-29 6:47 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
3,512 | $1.45 | $5,092 | 143,875 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-25 Exercise |
2024-11-27 4:08 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
25,219 | $0 | 908,778 (Direct) |
View |
| 2024-11-25 Exercise |
2024-11-27 4:06 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
9,034 | $0 | 144,547 (Direct) |
View |
| 2024-08-25 Exercise |
2024-09-12 6:13 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
25,219 | $0 | 908,778 (Direct) |
View |
| 2024-08-25 Exercise |
2024-09-12 6:10 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
9,034 | $0 | 144,547 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 7:50 pm |
N/A 2034-06-20 |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 7:49 pm |
N/A 2034-06-20 |
Viracta Therapeutics Inc. | VIRX | Borellini Flavia Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 7:48 pm |
N/A 2034-06-20 |
Viracta Therapeutics Inc. | VIRX | Chung Jane Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 7:47 pm |
N/A 2034-06-20 |
Viracta Therapeutics Inc. | VIRX | Murphy Samuel Lafayette Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 7:46 pm |
N/A 2034-06-20 |
Viracta Therapeutics Inc. | VIRX | DARCY THOMAS E Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 7:44 pm |
N/A 2034-06-20 |
Viracta Therapeutics Inc. | VIRX | Simon Barry J. Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 7:43 pm |
N/A 2034-06-20 |
Viracta Therapeutics Inc. | VIRX | Barlow Jane F Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 7:40 pm |
N/A 2034-06-20 |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
68,750 | $0 | 68,750 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 7:39 pm |
N/A 2034-06-20 |
Viracta Therapeutics Inc. | VIRX | Rubino Stephen Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-05-25 Exercise |
2024-05-29 7:12 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
9,035 | $0 | 144,547 (Direct) |
View |
| 2024-05-25 Exercise |
2024-05-29 7:07 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
25,219 | $0 | 908,778 (Direct) |
View |
| 2024-05-14 Option Award |
2024-05-16 4:26 pm |
N/A 2034-05-14 |
Viracta Therapeutics Inc. | VIRX | Faerm Michael E. Chief Financial Officer |
500,000 | $0 | 500,000 (Direct) |
View |
Ownership |
2024-03-22 4:07 pm |
N/A 2032-11-14 |
Viracta Therapeutics Inc. | VIRX | Burcar Melody Senior VP, Finance |
0 | $0 | 260,750 (Direct) |
View |
| 2024-03-12 Option Award |
2024-03-13 8:36 pm |
N/A 2034-03-12 |
Viracta Therapeutics Inc. | VIRX | Rothera Mark President and CEO |
475,000 | $0 | 475,000 (Direct) |
View |
| 2024-03-12 Option Award |
2024-03-13 8:33 pm |
N/A 2034-03-12 |
Viracta Therapeutics Inc. | VIRX | Cohen Darrel P. Chief Medical Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2024-03-12 Option Award |
2024-03-13 8:29 pm |
N/A 2034-03-12 |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-02-25 Exercise |
2024-02-27 7:58 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
25,219 | $0 | 908,778 (Direct) |
View |
| 2024-02-25 Exercise |
2024-02-27 7:56 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
9,034 | $0 | 144,547 (Direct) |
View |
| 2024-02-25 Exercise |
2024-02-27 7:54 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
6,889 | $0 | 136,750 (Direct) |
View |
| 2023-11-25 Exercise |
2023-11-28 7:06 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
6,889 | $0 | 140,155 (Direct) |
View |
| 2023-11-25 Exercise |
2023-11-28 7:03 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
25,219 | $0 | 908,778 (Direct) |
View |
| 2023-11-25 Exercise |
2023-11-28 7:01 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
9,034 | $0 | 144,547 (Direct) |
View |
| 2023-08-25 Exercise |
2023-08-29 6:52 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
25,219 | $0 | 908,778 (Direct) |
View |
| 2023-08-25 Exercise |
2023-08-29 6:49 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
9,034 | $0 | 144,547 (Direct) |
View |
| 2023-08-25 Exercise |
2023-08-29 6:47 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
6,888 | $0 | 143,875 (Direct) |
View |
| 2023-08-16 Option Award |
2023-08-18 4:51 pm |
N/A 2033-08-16 |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-08-16 Option Award |
2023-08-18 4:46 pm |
N/A 2033-08-16 |
Viracta Therapeutics Inc. | VIRX | Cohen Darrel P. Chief Medical Officer |
500,000 | $0 | 500,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 6:49 pm |
N/A 2033-06-08 |
Viracta Therapeutics Inc. | VIRX | Simon Barry J. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 6:41 pm |
N/A 2033-06-08 |
Viracta Therapeutics Inc. | VIRX | Rubino Stephen Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 6:34 pm |
N/A 2033-06-08 |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 6:28 pm |
N/A 2033-06-08 |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 6:26 pm |
N/A 2033-06-08 |
Viracta Therapeutics Inc. | VIRX | Murphy Samuel Lafayette Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 6:22 pm |
N/A 2033-06-08 |
Viracta Therapeutics Inc. | VIRX | DARCY THOMAS E Director |
40,000 | $0 | 40,000 (Direct) |
View |